MMP9 and breast carcinoma: In conclusion, to our knowledge, this is the only study that has evaluated the prognostic role of preoperative serum lipocalin-2 and combined effect of lipocalin-2 and MMP-9 in patients with operable breast cancer suggesting that the elevated levels of lipocalin-2 and MMP-9 are associated with reduced breast cancer survival.